Cerebral Palsy Landing Page
TrainFES offers rehabilitation alternatives for people with motor paralysis, such as cerebral palsy, using electrical pulses to activate muscles alongside guided exercises by medical staff.

TrainFES: A cost-effective, home-based digital neuro-rehabilitation platform for paralysis patients.
trainfes.comCrawled Nov 6, 2026
TrainFES offers rehabilitation alternatives for people with motor paralysis, such as cerebral palsy, using electrical pulses to activate muscles alongside guided exercises by medical staff.
TrainFES provides rehabilitation options for motor paralysis caused by stroke, using electrical muscle stimulation combined with medical team-led exercises.
TrainFES won the 2020 Innovatón organized by Fundación Teletón, Claro, Huawei, and the UC Innovation Center. With support from CCU and Copec, TrainFES provides advanced technology-based neurorehabilitation across all Teletón centers in Chile.
TrainHealth receives FDA clearance for **TrainFES Advanced**, a neurological rehabilitation device targeting stroke and spinal cord injury patients. The company aims to serve over 8 million U.S. individuals affected by these conditions. TrainHealth positions the technology as an advanced solution for improving rehabilitation outcomes.
TrainHealth’s **TrainFES Advanced** device secures FDA clearance for smart electrical stimulation therapy in stroke and spinal cord injury rehabilitation. The system targets neurological recovery by delivering controlled electrical pulses to affected muscles. TrainHealth specializes in wearable solutions for motor function restoration in patients with mobility impairments.
TrainHealth receives FDA clearance for its **TrainFES Advanced** device, a neurological rehabilitation tool targeting patients with stroke or spinal cord injury sequelae. The company, based in Palo Alto, aims to address a market of over 8 million U.S. individuals affected by these conditions. The new device builds on existing rehabilitation technologies to enhance recovery outcomes.
Chile-based **TrainFES** secures a **$1.4 million seed round** led by Amarena and Invexor to expand into the US market. The company specializes in **neurological and remote rehabilitation technology**, aiming to improve patient access to care through digital solutions. Since its founding in 2013, TrainFES has focused on developing medical tech for neurological disease recovery.